Recombinant varicella zoster virus glycoprotein e antigen
5 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Recombinant varicella zoster virus glycoprotein e antigen for alzheimer disease | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Recombinant varicella zoster virus glycoprotein e antigen for cardiovascular diseases | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Recombinant varicella zoster virus glycoprotein e antigen for dementia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Recombinant varicella zoster virus glycoprotein e antigen for herpes zoster | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 3 |
| Recombinant varicella zoster virus glycoprotein e antigen for myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |